Efficacy of temsirolimus in metastatic chromophobe renal cell carcinoma

BACKGROUND: Renal cell carcinoma (RCC) is a histopathologically and molecularly heterogeneous disease with the chromophobe subtype (chRCC) accounting for approximately 5% of all cases. The median overall survival of advanced RCC has improved significantly since the advent of tyrosine kinase inhibito...

Descripción completa

Detalles Bibliográficos
Autores principales: Venugopal, Balaji, Ansari, Jawaher, Aitchison, Michael, Tho, Lye Mun, Campbell, Roderick, Jones, Rob J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3679738/
https://www.ncbi.nlm.nih.gov/pubmed/23688003
http://dx.doi.org/10.1186/1471-2490-13-26

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3679738/
https://www.ncbi.nlm.nih.gov/pubmed/23688003
http://dx.doi.org/10.1186/1471-2490-13-26

Ejemplares similares